# Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

> clinical trial · VERIFIED · 2026-06-30

Status: RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Myeloid Leukemia, Philadelphia Positive

- Company: Novartis Pharmaceuticals
- Sector: pharma
- Primary source: https://clinicaltrials.gov/study/NCT04925479

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.